TrialClinical pharmacology and therapeutics2010

Promoter polymorphisms in the β-2 adrenergic receptor are associated with drug-induced gene expression changes and response in acute lymphoblastic leukemia.

N Pottier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.